Employees Provident Fund Board’s Boston Scientific BSX Stock Holding History

Employees Provident Fund Board’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$143M	Buy	3,358,700 +1,224,109	+57%	+$66.5M	0.82%	35
2026 Q1	$134M	Hold	2,134,591	–	–	1.01%	35
2025 Q4	$204M	Hold	2,134,591	–	–	1.5%	25
2025 Q3	$208M	Buy	2,134,591 +126,761	+6%	+$13.1M	1.67%	23
2025 Q2	$216M	Buy	2,007,830 +621,213	+45%	+$62.9M	1.86%	20
2025 Q1	$140M	Buy	1,386,617 +1,125,651	+431%	+$113M	1.59%	22
2024 Q4	$23.3M	Buy	+260,966	New	+$23M	0.29%	57

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Employees Provident Fund Board's BSX Position: Q2 2026 in Review

Employees Provident Fund Board increased its Boston Scientific (BSX) stake by 57% in Q2 2026, buying an estimated $66.5M and bringing the position to 3,358,700 shares worth $143M. The position accounts for 0.82% of the portfolio, ranked #35.

Employees Provident Fund Board first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $216M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Employees Provident Fund Board held 3,358,700 shares of Boston Scientific worth $143M as of Q2 2026.
Employees Provident Fund Board bought 1,224,109 Boston Scientific shares in Q2 2026, an estimated $66.5M.
Boston Scientific made up 0.82% of Employees Provident Fund Board's portfolio in Q2 2026, its #35 holding.
Employees Provident Fund Board first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
Employees Provident Fund Board's Boston Scientific position peaked at $216M in Q2 2025.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Employees Provident Fund Board's 13F filing for Q2 2026, filed 12 Aug 2026.